Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evidence suggests a relationship between sleep deprivation and cardiovascular disease. The investigators wish to determine whether 9 nights of modest sleep restriction results in activation of cardiovascular disease mechanisms, thus potentially increasing the risk of cardiovascular disease. The investigators hypothesize that sleep restriction will result in elevated blood pressure, inflammation, and neurocognitive deficits.
Evidence suggests a relationship between sleep deprivation and cardiovascular disease. Voluntary sleep restriction is common, with 28% of the US adult population reports getting 6 or fewer hours of sleep per night, and those who do are 24% more likely to have cardiovascular disease and have twice the risk of hypertension. Insufficient sleep may conceivably be one of the most common, and most preventable, cardiovascular risk factors. The investigators wish to determine whether 9 nights of modest sleep restriction results in activation of cardiovascular disease mechanisms, thus potentially increasing the risk of cardiovascular disease. The investigators will combine our cardiovascular studies with state-of-the art sleep monitoring and neurocognitive tests to provide unambiguous data on the physiologic effects of sleep restriction. Together, the investigators findings will help explain whether the reduced sleep duration in the general population may be contributing to the current epidemic of cardiovascular disease, and suggest strategies to reduce this risk.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| sleep restriction | Experimental | restricted sleep during the experimental period |
|
| normal sleep | No Intervention | normal sleep during the experimental period |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| sleep restriction | Behavioral | restricted sleep |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in blood pressure | Change in mean arterial blood pressure over 24 hours, measured during acclimation, experimental, and recovery timepoints over the study period. | throughout 16 days |
| Measure | Description | Time Frame |
|---|---|---|
| Change in catecholamines | Change in catecholamines, measured during acclimation, experimental, and recovery | throughout 16 days |
| Change in endothelial function | Change in endothelial function, measured during acclimation, experimental, and recovery timepoints. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in sleep architecture and sleepiness | Change in sleep architecture and sleepiness, measured during acclimation, experimental, and recovery timepoints. | throughout 16 days |
| Change in neurocognitive function |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Virend K Somers, MD, PhD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 42133047 | Derived | Greenlund IM, Covassin N, Bukartyk J, St Louis EK, Calvin AD, Somers VK. Heart rate and vascular responses to spontaneous arousals following experimental sleep restriction. Am J Physiol Heart Circ Physiol. 2026 Jun 1;330(6):H2058-H2067. doi: 10.1152/ajpheart.00123.2026. Epub 2026 May 14. |
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D012892 | Sleep Deprivation |
| ID | Term |
|---|---|
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |
| D009461 | Neurologic Manifestations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| throughout 16 days |
| Change in baroreflex sensitivity | Change in baroreflex sensitivity, measured during acclimation, experimental, and recovery | throughout 16 days |
| Change in arterial stiffness | Change in arterial stiffness, measured during acclimation, experimental, and recovery timepoints. | throughout 16 days |
| Change in electrocardiographic characteristics | Change in electrocardiographic characteristics, measured during acclimation, experimental, and recovery timepoints. | throughout 16 days |
| Change in markers of inflammation | Change in markers of inflammation, measured during acclimation, experimental, and recovery timepoints. | throughout 16 days |
| Change in fat tissue characteristics | Change in fat tissue characteristics, determined by analysis of a fat biopsy sample. | throughout 16 days |
Change in neurocognitive function, measured during acclimation, experimental, and recovery timepoints
| throughout 16 days |
| Change in cardiovascular reactivity | Change in cardiovascular reactivity, measured during acclimation, experimental, and recovery timepoints. | throughout 16 days |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001523 | Mental Disorders |